Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector (Q38808216)

6 September 2017

title

Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector (English)

1 reference

6 September 2017

1 reference

Jonathan M O Rawson

1

1 reference

6 September 2017

Christine L Clouser

series ordinal

2

1 reference

6 September 2017

Louis M Mansky

series ordinal

3

1 reference

6 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Methods in Molecular Biology

6 September 2017

published in

1 reference

6 September 2017

volume

1354

1 reference

6 September 2017

page(s)

71-88

1 reference

describes a project that uses

6 September 2017

1 reference

Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

A new cell-based assay for measuring the forward mutation rate of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Fifteen to twenty percent of HIV substitution mutations are associated with recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

The origin of genetic diversity in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Mechanisms and factors that influence high frequency retroviral recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Exploiting drug repositioning for discovery of a novel HIV combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Variation of HIV-1 mutation spectra among cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Interrelationship between HIV-1 fitness and mutation rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Substantial biases in ultra-short read data sets from high-throughput DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and genome analyzer systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Sequence-specific error profile of Illumina sequencers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Analyzing fidelity of DNA polymerases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Analyzing the fidelity of reverse transcription and transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Novel inhibitors of human immunodeficiency virus type 2 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

A rapid PCR fidelity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Fidelity of DNA polymerases in DNA amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

BEAMing up for detection and quantification of rare sequence variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Error Rate Comparison during Polymerase Chain Reaction by DNA Polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

Detection and quantification of rare mutations with massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/978-1-4939-3046-3_6

10.1007/978-1-4939-3046-3_6

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference